Diabetes

Pharmacist-led collaborative care management programs for type 2 diabetes are associated with better glycemic control and lower health care costs compared with primary care settings that lack these programs.

A combination of blocking glucagon and insulin replacement therapy could normalize blood sugar levels.

Diabetes isn't the only therapeutic class that has seen substantial drug price hikes over the past decade.

Faulty protein kinases can lead to conditions such as diabetes, cancer, and cardiovascular disease.

Limited evidence has examined dual therapy in treatment-experienced diabetes patients.

Metformin and DPP-4 inhibitor dual therapy provides less durable glycemic control than the addition of sulfonylureas or TZD to metformin in diabetics.

Diabetes costs the United States more than $300 billion annually.

Cardiovascular disease (CVD) costs the United States $444 billion each year.

The leading cause of death worldwide is preventable.

Two new outcome studies for Jardiance will be conducted in patients with type 2 diabetes.

Affordable Care Act provides reimbursements for diabetes self-management education and support programs for pharmacists with recognized credentials.

Patients with chronic conditions who receive care from pharmacists may be more likely to reach their blood glucose, blood pressure, and cholesterol goals.

Diabetes costs the United States more than $300 billion annually, so concerted efforts are needed to manage this disease.

Study highlights importance of a healthy lifestyle in patients with diabetes.

Diabetes has the dubious distinction of being the 7th leading cause of death and the leading cause of kidney failure, non-traumatic lower-limb amputations, and blindness in the United States.

Pharmacy benefit manager releases data showing the cost of insulin grew by 8%.

TZD-based medicines effectively improve glucose uptake.

Metformin has been found the most effective type 2 diabetes drug.

By 2014, 8.5% of the global population had diabetes.

Neighborhoods with greater resources for healthy diets and physical activity may be associated with lower risk for type 2 diabetes.

The number of adults living with diabetes worldwide has nearly quadrupled from 108 million in 1980 to 422 million in 2014.

This Continuing Education activity is supported by an educational grant from Novo Nordisk.

Improving insulin signaling in the brain may reduce the likelihood patients with Alzheimer's disease develop diabetes.

Pharmacists can aggressively intervene to adjust medications when patients’ diabetes is uncontrolled.

Did you know that diabetes is a common problem in prisons?